danusertib
Term · Oncology and biomedicine · MLC-T-ONC-012912
A small-molecule 3-aminopyrazole derivative with potential antineoplastic activity. Dalotuzumab binds to and inhibits the Aurora kinases, which may result in cell growth arrest and apoptosis in tumor cells in which Aurora kinases are overexpressed. This agent may preferentially bind to and inhibit Aurora B kinase. Aurora kinases, a family of serine-threonine kinases, are important regulators of cellular proliferation and division.
| Identifier | MLC-T-ONC-012912 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Aurora kinase inhibitor PHA-739358 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012912",
"term": "danusertib",
"field": "Oncology and biomedicine",
"definition": "A small-molecule 3-aminopyrazole derivative with potential antineoplastic activity. Dalotuzumab binds to and inhibits the Aurora kinases, which may result in cell growth arrest and apoptosis in tumor cells in which Aurora kinases are overexpressed. This agent may preferentially bind to and inhibit Aurora B kinase. Aurora kinases, a family of serine-threonine kinases, are important regulators of cellular proliferation and division.",
"synonyms": [
"Aurora kinase inhibitor PHA-739358"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/danusertib/"
}
Record 5,679 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.